Rapid weight loss itself can trigger muscle soreness as the body adapts to reduced caloric intake and changes in muscle glycogen stores
For most people who dont have an insulin deficiency, the American Diabetes Association now recommends trying a GLP-1 receptor agonist before starting insulin
Novo Nordisk to end semaglutide kidney study early due to strong efficacy signals owenhaskins Oct 12, 2023 1 min read Novo Nordisk is ending its Phase III FLOW trial ahead of schedule after an interim analysis of the kidney outcomes study of semaglutide found a very high likelihood of study success
The transition is genuinely challenging, and managing this dose requires an active, deliberate strategy rather than passive endurance
The endpoint was analysed by a linear normal model based on the log-transformed values and back-transformed to provide dose ratios alongside 95% confidence intervals
Did you know that an estimated 80% of women globally live with a hormonal imbalance, yet many are told by their providers that their lab results are perfectly normal
